Login / Signup

Early use of oral semaglutide in the UK: A cost-effectiveness analysis versus continuing metformin and SGLT-2 inhibitor therapy.

Hongye RenSasha BerrySamuel Joseph Paul MalkinBarnaby HuntStephen Bain
Published in: BMJ open (2023)
NCT02863419.
Keyphrases
  • cross sectional
  • medical education
  • mesenchymal stem cells
  • bone marrow
  • data analysis
  • replacement therapy